SignIn
Kerala Kaumudi Online
Thursday, 29 October 2020 8.04 PM IST

One in seven volunteers report side effects after taking Sputnik V; out of the selected 40,000 volunteers vaccine test conducted only in 300

russia

MOSCOW: One in seven volunteers have complained of side effects, including weakness and muscle pain after receiving the Sputnik V coronavirus vaccine, Russian health minister Mikhail Murashko said.

Results of the phase 1/2 trials of the vaccine published in the Lancet show no serious adverse effects and a stable immune response in 100 per cent of participants. Final clinical trials of the Sputnik V COVID-19 vaccine are currently ongoing.

Meanwhile, the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr Reddy’s Laboratories Ltd, a global pharmaceutical company headquartered out of India, have agreed to cooperate on clinical trials and distribution of 100 million of doses of the Sputnik V vaccine in India.

“Approximately 14 per cent have small complaints of weakness, muscle pain for 24 hours and an occasional increase in body temperature,” Murashko was quoted as saying by the state-run TASS news agency.

Murashko said the symptoms ‘level off’ by the next day, adding the complications are described in the instructions and are predictable.

The TASS, citing Murashko, reported more than 300 out of the announced 40,000 study volunteers have been inoculated so far. Volunteers are expected to receive a second shot of the vaccine within 21 days of the first dose, added the report.

According to Murashko, the general population could be given Sputnik V in late November or early December, even as developers began distributing small batches of the vaccine across Russian regions in parallel with the Phase 3 trials.

JOIN THE DISCUSSION
TAGS: SPUTNIK V, VOLUNTEERS, 300, WEAKNESS AND MUSCLE PAIN, CORONAVIRUS VACCINE, RUSSIA, MIKHAIL MURASHKO, LANCET
KERALA KAUMUDI EPAPER
TRENDING IN INDIA
TRENDING IN INDIA
X
Lorem ipsum dolor sit amet
consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
We respect your privacy. Your information is safe and will never be shared.